Sumitomo Mitsui Trust Group
RVMD icon

Sumitomo Mitsui Trust Group’s Revolution Medicines RVMD Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.4M Buy
306,300
+35,328
+13% +$5.16M 0.03% 422
2026
Q1 		$26.4M Buy
270,972
+265,474
+4,829% +$26.8M 0.02% 584
2025
Q4 		$438K Buy
+5,498
New +$361K ﹤0.01% 964

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Sumitomo Mitsui Trust Group's RVMD Position: Q2 2026 in Review

Sumitomo Mitsui Trust Group increased its Revolution Medicines (RVMD) stake by 13% in Q2 2026, buying an estimated $5.16M and bringing the position to 306,300 shares worth $57.4M. The position accounts for 0.03% of the portfolio, ranked #422.

Sumitomo Mitsui Trust Group first reported a position in RVMD in Q4 2025 and has held it in 3 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Sumitomo Mitsui Trust Group held 306,300 shares of Revolution Medicines worth $57.4M as of Q2 2026.
  • Sumitomo Mitsui Trust Group bought 35,328 Revolution Medicines shares in Q2 2026, an estimated $5.16M.
  • Revolution Medicines made up 0.03% of Sumitomo Mitsui Trust Group's portfolio in Q2 2026, its #422 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Revolution Medicines in Q4 2025 and has held it in 3 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2026, filed 30 Jul 2026.